Mml Investors Services, LLC Neurocrine Biosciences Inc Transaction History

Mml Investors Services, LLC

$27.4 Billion
Q3 2024

A detailed history of Mml Investors Services, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Mml Investors Services, LLC holds 9,833 shares of NBIX stock, worth $1.35 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,833

Previous 9,962 1.29%

Holding current value

$1.35 Million

Previous $1.37 Million 17.36%

% of portfolio

0.0%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$114.58 - $153.15 $14,780 - $19,756	-129 Reduced 1.29%	9,833 $1.13 Million
Q2 2024 Aug 14, 2024	SELL	$130.86 - $143.19 $9,683 - $10,596	-74 Reduced 0.74%	9,962 $1.37 Million
Q1 2024 May 14, 2024	BUY	$130.4 - $143.74 $359,382 - $396,147	2,756 Added 37.86%	10,036 $1.38 Million
Q4 2023 Feb 14, 2024	BUY	$106.07 - $132.76 $128,875 - $161,303	1,215 Added 20.03%	7,280 $959,000
Q3 2023 Nov 14, 2023	BUY	$94.02 - $117.1 $10,060 - $12,529	107 Added 1.8%	6,065 $682,000
Q2 2023 Aug 14, 2023	SELL	$89.53 - $104.87 $85,411 - $100,045	-954 Reduced 13.8%	5,958 $562,000
Q1 2023 May 12, 2023	SELL	$94.11 - $123.02 $131,001 - $171,243	-1,392 Reduced 16.76%	6,912 $700,000
Q4 2022 Feb 13, 2023	BUY	$106.72 - $127.06 $129,344 - $153,996	1,212 Added 17.09%	8,304 $992,000
Q3 2022 Nov 14, 2022	BUY	$92.03 - $107.81 $11,319 - $13,260	123 Added 1.76%	7,092 $753,000
Q2 2022 Aug 12, 2022	BUY	$75.79 - $100.07 $24,177 - $31,922	319 Added 4.8%	6,969 $679,000
Q1 2022 May 13, 2022	BUY	$72.45 - $94.81 $140,842 - $184,310	1,944 Added 41.31%	6,650 $623,000
Q4 2021 Feb 14, 2022	SELL	$79.65 - $106.22 $298,846 - $398,537	-3,752 Reduced 44.36%	4,706 $401,000
Q3 2021 Nov 15, 2021	SELL	$86.18 - $99.03 $11,720 - $13,468	-136 Reduced 1.58%	8,458 $811,000
Q2 2021 Aug 13, 2021	BUY	$89.43 - $102.27 $171,526 - $196,153	1,918 Added 28.73%	8,594 $836,000
Q1 2021 May 14, 2021	BUY	$87.57 - $119.4 $17,951 - $24,477	205 Added 3.17%	6,676 $649,000
Q4 2020 Feb 12, 2021	SELL	$86.91 - $108.33 $137,143 - $170,944	-1,578 Reduced 19.6%	6,471 $620,000
Q3 2020 Nov 13, 2020	BUY	$96.16 - $135.15 $468,587 - $658,585	4,873 Added 153.43%	8,049 $774,000
Q2 2020 Aug 14, 2020	BUY	$85.09 - $130.36 $270,245 - $414,023	3,176 New	3,176 $387,000
Q1 2020 May 14, 2020	SELL	$75.11 - $113.76 $146,689 - $222,173	-1,953 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$86.8 - $118.57 $169,520 - $231,567	1,953 New	1,953 $210,000

Others Institutions Holding NBIX

# of Institutions

626

Shares Held

94M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.1B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mml Investors Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mml Investors Services, LLC with notifications on news.

Account

Mml Investors Services, LLC Neurocrine Biosciences Inc Transaction History